Jonathan Milner Net Worth

Net Worth: $157.5 Million
  • Source of Wealth:

  • Age:

  • Nationality:

More Stats View More


Working as a research fellow at Cambridge University, he identified the market opportunity in supplying high-quality antibodies to support protein interaction studies. Abcam supplies more than 45,000 antibodies that track proteins in the human genome project to 50 laboratories worldwide. It floated on AIM in 2005. Profits rose 58.4% in 2009-10, pushing the shares to record levels. Abcam is worth about £690m and Milner has a £93m stake. Share sales add £12m.

Earnings & Financial Data ?
Choose Year

Earnings 2016

Asset Oct. 2016
Series A funding for Healx along with Amadeus Capital Partners (Lead)
Asset Jun. 2016
Seed funding for GeneAdviser (Lead)
Asset May. 2016
Series B funding for Definigen along wiht 5 investors
Asset May. 2016
Series A funding for SyndicateRoom along with Unicorn AIM VCT

Earnings 2015

Asset Nov. 2015
Seed funding for Eagle Genomics along with 2 investors
Asset Oct. 2015
Series A funding for GeoSpock Ltd. along with 3 investors (Lead)
Asset Sep. 2015
Venture funding for Desktop Genetics along with 3 investors
Asset Mar. 2015
Seed funding for PhoreMost along with 4 investors
Show all earnings